Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
NBTX · NASDAQ · Pharmaceutical Preparations · Foreign private issuer
Nanobiotix (NBTX) · oqro.io/stocks/NBTX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
No open-market purchase by an insider of Nanobiotix is on record in SEC filings since 2006.
No open-market sale by an insider of Nanobiotix (NBTX) was filed with the SEC in the last 90 days.
No trade in Nanobiotix (NBTX) was disclosed by a member of Congress in the last 12 months.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
$30.66−1.59 (−4.95%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
+51.2% (+$10.39) from Nov 13, 2025 to Nov 13, 2026 · adjusted daily closes
No disclosed open-market insider trades, politician trades or fund 13F changes in this period.
Adjusted close went from $20.27 on Nov 13, 2025 to $30.66 on Nov 13, 2026 (+51.2%). Disclosed in this range: 0 insider trades, 0 pre-arranged insider sales, 0 Congress trades.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Pharmaceutical Preparations company based in Paris, France. Foreign private issuer: reports on Form 20-F or 40-F. Its directors and officers file insider-trading forms (Form 4) only since 18 March 2026.
Last 12 months
+51.2%
Market value
$1.48B
S&P 500 +12.3% over the same dates. Prices adjusted for splits and dividends.
Short interest: 170K shares sold short (0.4% of shares outstanding), −13.4% vs the previous count, 1.4 days of normal trading to buy them back. FINRA, as of Oct 30, 2026.
Nothing reported yet
New filings show up here as soon as they are processed.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Fails to deliver: 38K shares (about $1.28M) were not delivered on time for settlement on Sep 25, 2026. SEC fails-to-deliver data.
Fails to deliver have many causes, including processing delays, and are often resolved within days.
Against the S&P 500 over the year
Since Nov 11, 2025, NBTX is up 46.5% and the index fund is up 10.4%: 36 points ahead of the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much NBTX moves
End-of-day prices. These figures describe the past year and say nothing about what comes next.
